Form 8-K - Current report:
SEC Accession No. 0001213900-24-102169
Filing Date
2024-11-25
Accepted
2024-11-25 16:15:07
Documents
13
Period of Report
2024-11-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0222393-8k_enzobio.htm   iXBRL 8-K 26064
  Complete submission text file 0001213900-24-102169.txt   197770

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE enz-20241122.xsd EX-101.SCH 3000
3 XBRL LABEL FILE enz-20241122_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE enz-20241122_pre.xml EX-101.PRE 22350
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0222393-8k_enzobio_htm.xml XML 3555
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 241496088
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)